Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France

Published:2017-01-19 Issue:1 Volume:12 Page:e0170258
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Baro Emilie^ORCID,Galperine Tatiana,Denies Fanette,Lannoy Damien,Lenne Xavier,Odou Pascal,Guery Benoit,Dervaux Benoit

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference85 articles.

1. Diversity and Evolution in the Genome of Clostridium difficile;DR Knight;Clin Microbiol Rev,2015

2. Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012;DW Eyre;Euro Surveill,2015

3. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach;K Desai;BMC Infect Dis,2016

4. Can we identify patients at high risk of recurrent Clostridium difficile infection?;CP Kelly;Clin Microbiol Infect,2012

5. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study;DN Shah;J Hosp Infect,2016

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Framework for developing cost-effectiveness analysis threshold: the case of Egypt;Journal of the Egyptian Public Health Association;2024-06-03

2. Implementing an electronic gate keeping (EGK) intervention at a rural academic tertiary hospital in South Africa over a two-year period: A cost effectiveness analysis;2023-12-12

3. Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis;Frontiers in Medicine;2023-10-02

4. Clustering Disease of Clostridioides Difficile Infection: Implication for the Management in Internal Medicine;Microbiology Research;2023-09-15

5. Fecal Transplant: The Benefits and Harms of Fecal Microbiota Transplantation;Clinical Understanding of the Human Gut Microbiome;2023